HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Iris melanocytic tumors are neoplasms that originate in the iris, the colored part of the eye. These tumors typically arise from melanocytes, the pigment-producing cells present in the iris. While many iris melanocytic tumors are benign and do not pose a significant threat to vision or overall health, some may exhibit malignant characteristics. Benign iris melanocytic tumors, such as iris nevi, are often discovered incidentally during routine eye examinations. These tumors are usually small and slow-growing, causing minimal disruption to normal eye function. In contrast, malignant iris melanocytic tumors, like iris melanomas, can be more aggressive and have the potential to spread to other parts of the eye or body. Diagnosis of iris melanocytic tumors involves a thorough eye examination, often utilizing imaging techniques such as ultrasound or optical coherence tomography. In some cases, a biopsy may be performed to determine the nature of the tumor and its potential for malignancy. Treatment options for benign iris melanocytic tumors may involve regular monitoring and surveillance to track any changes in size or characteristics. Malignant tumors, however, may require more aggressive interventions, including surgery, radiation therapy, or targeted therapies. Regular eye examinations play a crucial role in the early detection and management of iris melanocytic tumors. As with any medical condition, individuals are advised to consult with an ophthalmologist for proper evaluation, diagnosis, and appropriate management based on their specific case.
